Condition category
Mental and Behavioural Disorders
Date applied
30/09/2004
Date assigned
30/09/2004
Last edited
04/04/2013
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Mr Paul Townsend

ORCID ID

Contact details

Clinical Nurse Specialist
West Suffolk Drugs Service
Blomfield House
Looms Lane
Bury St Edmunds
IP33 1HE
United Kingdom
+44 (0)1284 775275

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N0029134729

Study information

Scientific title

Acronym

Study hypothesis

How does a safer injecting training session alter injecting behaviour of injecting drug users

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Other

Trial type

Other

Patient information sheet

Condition

Drug abuse

Intervention

Sample of 50 subjects will be randomly assigned to a control group of 25 and a treatment group of 25. A pre-test questionnaire will be completed by all 50 subjects. The treatment group will receive a safer injecting training session lasting one hour which will include routes of administration, overview of the cardiovascular system, health risk of injecting street drugs and preparation of drugs and injecting equipment. One month after the training session a repeat questionnaire on injecting behaviour will be completed by all 50 subjects. The sample will be generated through a snowball technique.

Intervention type

Other

Phase

Not Applicable

Drug names

Primary outcome measures

Analysis will examine the change in magnitude in the variable of interest in each group between baseline and follow-up measurements. Impact analysis will be used to attribute causal influence to the safer injecting training.

Secondary outcome measures

Not provided at time of registration

Overall trial start date

01/02/2004

Overall trial end date

01/09/2004

Reason abandoned

Eligibility

Participant inclusion criteria

T1. he sample group will be selected from clients who inject drugs and who are accessing treatment from the West Suffolk Drugs Service.
2. All clients participating to be over 18 years old and younger than 65 years old.

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

50

Participant exclusion criteria

Does not meet inclusion criteria

Recruitment start date

01/02/2004

Recruitment end date

01/09/2004

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Clinical Nurse Specialist
Bury St Edmunds
IP33 1HE
United Kingdom

Sponsor information

Organisation

Department of Health

Sponsor details

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Sponsor type

Government

Website

http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Not defined

Funder name

Local Health Partnerships NHS Trust

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes